de Vries-van der Zwan A, van der Pol M A, Besseling A C, de Waal L P, Boog C J
Department of Transplantation Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, University of Amsterdam.
Bone Marrow Transplant. 1998 Jul;22(1):91-8. doi: 10.1038/sj.bmt.1701277.
Previously, we and others have demonstrated in several animal models that the establishment of stable haematopoietic chimerism through allogeneic bone marrow transfusion provides an effective means for the development of specific transplantation tolerance. However, a major limitation to the clinical application of allogeneic bone marrow transfusion in immunosuppressed recipients for induction of tolerance to solid grafts, is the risk of graft-versus-host disease (GVHD). Therefore, it is important to identify the cell population needed for the induction of mixed chimerism and tolerance. Haematopoietic stem cells have the capacity of self-renewal and multilineage differentiation, and have been shown to reduce the risk of GVHD. We studied transfusion of two rich sources of stem cells, namely allogeneic fetal liver cells and a subset of purified bone marrow-derived progenitor cells (c-kit+) into anti-T cell monoclonal antibody-treated, low-dose irradiated recipient mice. Our data revealed that stable multilineage mixed chimerism and permanent donor-specific tolerance for skin, even when transplanted directly following conditioning, can be successfully achieved in this way, with no signs of GVHD.
此前,我们和其他人已在多种动物模型中证明,通过异体骨髓输血建立稳定的造血嵌合体为诱导特异性移植耐受提供了一种有效手段。然而,在免疫抑制受体中进行异体骨髓输血以诱导对实体移植物的耐受,其临床应用的一个主要限制是移植物抗宿主病(GVHD)的风险。因此,确定诱导混合嵌合体和耐受所需的细胞群体很重要。造血干细胞具有自我更新和多谱系分化的能力,并已被证明可降低GVHD的风险。我们研究了将两种丰富的干细胞来源,即异体胎肝细胞和纯化的骨髓来源祖细胞亚群(c-kit+)输注到经抗T细胞单克隆抗体处理、低剂量照射的受体小鼠体内。我们的数据显示,通过这种方式可以成功实现稳定的多谱系混合嵌合体以及对皮肤的永久供体特异性耐受,即使在预处理后直接移植也没有GVHD的迹象。